Compare XERS & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XERS | RAPP |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2018 | 2024 |
| Metric | XERS | RAPP |
|---|---|---|
| Price | $7.92 | $29.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.43 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 2.5M | 408.4K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $266,137,000.00 | N/A |
| Revenue This Year | $44.37 | N/A |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | N/A |
| 52 Week Low | $3.14 | $6.43 |
| 52 Week High | $10.08 | $42.27 |
| Indicator | XERS | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 49.19 |
| Support Level | $6.88 | $26.60 |
| Resistance Level | $8.42 | $30.79 |
| Average True Range (ATR) | 0.43 | 1.94 |
| MACD | 0.10 | -0.28 |
| Stochastic Oscillator | 70.38 | 38.67 |
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.